Point-of-Care Testing: An Overview and a Look to the Future

2001 ◽  
Vol 21 (2) ◽  
pp. 217-240 ◽  
Author(s):  
Elizabeth Lee-Lewandrowski ◽  
Kent Lewandrowski
2011 ◽  
Vol 96 (Supplement 1) ◽  
pp. Fa120-Fa121 ◽  
Author(s):  
K. S. King ◽  
S. Setty ◽  
K. Thompson ◽  
A. P. McGlennan ◽  
A. L. Wright

2021 ◽  
Vol 6 (1) ◽  
pp. 19
Author(s):  
Sascha Balakin ◽  
Bergoi Ibarlucea ◽  
Dmitry Belyaev ◽  
Larysa Baraban ◽  
Stefanie Hänsel ◽  
...  

The real-time monitoring of physiological parameters is essential for point-of-care testing. While nowadays routine tests are done through ex vivo analysis on frequently extracted blood, placing implantable sensors monitoring key blood parameters such as lactate, glucose, ions, and oxygen would mean a giant step forward in the care of critically ill patients, improving the response time in emergencies and diminishing the invasiveness of the measurements. The recent advances in microelectronics and nanotechnology are a promising technology enabling moving in that direction. The goal of our work is to develop arrays of electrochemical sensors with selective and hemocompatible coatings, allowing for the future implementation of such measurements in patients. We perform the analysis of blood parameters in a label-free and electrochemical manner which is compatible with the inevitable miniaturization in a real application. The tuneable composition of the layer will allow to pursue further applications in the future by modification of the receptor molecules and their concentrations.


2019 ◽  
Vol 57 (3) ◽  
pp. 308-311 ◽  
Author(s):  
Larry J. Kricka

Abstract Predictions about the future of laboratory medicine have had a mixed success, and in some instances they have been overambitious and incorrectly assessed the future impact of emerging technologies. Current predictions suggest a more highly automated and connected future for diagnostic testing. The central laboratory of the future may be dominated by more robotics and more connectivity in order to take advantage of the benefits of the Internet of Things and artificial intelligence (AI)-based systems (e.g. decision support software and imaging analytics). For point-of-care testing, mobile health (mHealth) may be in the ascendancy driven by healthcare initiatives from technology companies such as Amazon, Apple, Facebook, Google, IBM, Microsoft and Uber.


2001 ◽  
Vol 32 (4) ◽  
pp. 189-190
Author(s):  
Robyn Medeiros

Sign in / Sign up

Export Citation Format

Share Document